AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (November 11, 2003). doi:10.1152/ajprenal.00257.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/F564    most recent
00257.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kneuer, C.
Right arrow Articles by Honscha, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kneuer, C.
Right arrow Articles by Honscha, W.
Submitted on July 18, 2003
Accepted on November 8, 2003

The Sodium-Dependent Methotrexate Carrier-1 is Expressed in Rat Kidney: Cloning and Functional Characterization

Carsten Kneuer1, Kerstin U. Honscha2, and Walther Honscha1*

1 Institute of Veterinary Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Saxony, Germany
2 Institute of Veterinary Physiology, Faculty of Veterinary Medicine, University of Leipzig, Leipzig, Saxony, Germany

* To whom correspondence should be addressed. E-mail: honscha{at}vetmed.uni-leipzig.de.

Previous Northern blot studies suggested strong expression of a homologue to the sodiumdependent hepatocellular methotrexate transporter in the kidneys. Here, we report on the cloning of the cDNA for the renal methotrexate carrier isoform 1 (RK-MTX-1) and its functional characterization. Sequencing revealed 97% homology to the rat liver methotrexate carrier with an identical open reading frame. Differences were located in the 5'-untranslated region and resulted in the absence of putative regulatory elements (Barbie box, Ah/ARNT receptor) identified in the cDNA for the hepatocellular carrier. For functional characterization, MTX-1 cDNA was stably expressed in MDCK cells. A sodium-dependent transport of methotrexate with a Km of 41 µM and a Vmax of 337 pmol/mg protein and minute was observed. This uptake was blocked by the reduced folates dihydro- and tetrahydrofolate as well as by methotrexate itself. Folate was inhibiting only weakly, whereas 5- methyltetrahydrofolate was a strong inhibitor. Further inhibitors of the methotrexate transport included the bile acids cholate and taurocholate, and xenobiotics like bumetanide and BSP. PAH, ouabain, bumetanide, cholate, taurocholate, and acetyl salicylic acid were tested as potential substrates. However, none of these substances was transported by MTX-1. Further, expression of RK-MTX-1 in MDCK cells enhanced methotrexate toxicity in these cells 5-fold. Analysis of a fusion protein of RK-MTX-1 and the influenza virus HA-epitope by immunoblotting revealed a major band at 72 kDa within the cell membrane, but not in the soluble fraction of transfected MDCK. Indirect immunofluorescence staining revealed an exclusive localization of the carrier in the plasma membrane and by confocal laser scanning microscopy we were able to demonstrate that the protein is expressed in the serosal region of MDCK tubules grown in a morphogenic collagen gel model.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.